| Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI. | |
| | |
MedLine Citation:
|
PMID: 20602599 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To test whether the clinical efficiency of recombinant FSH (rFSH) and highly purified human menotrophin (hMG) differs in terms of pregnancy and live birth rates during the first treatment cycle of IVF or ICSI. DESIGN: Prospective cohort study. SETTING: Department of Gynecology and Obstetrics, Rikshospitalet, Oslo University Hospital. STUDY POPULATION: Records of 1,136 infertile couples undergoing their first IVF (n = 682) or ICSI (n = 454) treatments were reviewed. The effect of hMG and rFSH was analyzed for the IVF and ICSI groups separately. METHODS: Patients received long term down-regulation with GnRH agonist and controlled ovarian hyperstimulation with hMG or rFSH. Oocytes were fertilized by IVF or ICSI. Embryos were transferred on Day 2. MAIN OUTCOME MEASURES: Primary outcome measures were pregnancy and live birth rates, secondary outcome measures were duration of treatment, doses of hMG or rFSH applied, number of oocytes retrieved and the number and quality of embryos obtained. RESULTS: Similar pregnancy and live birth rates were observed with hMG and rFSH. Compared to hMG, treatment cycles with rFSH were characterized by significantly shorter stimulation, lower gonadotrophin consumption, and increased number of oocytes and embryos. CONCLUSION: We conclude that rFSH and hMG are equivalent in terms of clinical efficacy. |
| | |
Authors:
|
Sverre Bjercke; Tom Tanbo; Thomas Abyholm; Anne Omland; Hans Kristian Opøien; Peter Fedorcsak |
Related Documents
:
|
1500479 - Fallopian tube sperm perfusion used in a donor insemination programme. 3656299 - Planned parenthood experience with triphasil. 20548909 - The influence of pregnancy and menstruation on the deterioration of atopic dermatitis s... 1426389 - Intrauterine insemination after ovarian stimulation as a treatment for subfertility bec... 8195349 - Regulation of corpus luteum function. 14664409 - Effect of short follicular phase with follicular maturity on conception outcome. 10233849 - Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. 3426989 - Energy intake and physical activity during pregnancy in relation to maternal fat accret... 10719409 - Nutrition and multifetal pregnancy. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta obstetricia et gynecologica Scandinavica Volume: 89 ISSN: 1600-0412 ISO Abbreviation: Acta Obstet Gynecol Scand Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-19 Completed Date: 2010-08-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370343 Medline TA: Acta Obstet Gynecol Scand Country: England |
Other Details:
|
Languages: eng Pagination: 1053-60 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. sverre.bjercke@rikshospitalet.no |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Buserelin / therapeutic use Embryo, Mammalian Female Fertility Agents, Female / therapeutic use* Fertilization in Vitro Follicle Stimulating Hormone / therapeutic use* Hormones / therapeutic use* Humans Live Birth* Menotropins / therapeutic use* Oocytes Ovulation Induction / methods* Pregnancy Pregnancy Rate* Prospective Studies Sperm Injections, Intracytoplasmic Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Fertility Agents, Female; 0/Hormones; 57982-77-1/Buserelin; 61489-71-2/Menotropins; 9002-68-0/Follicle Stimulating Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Abstracts.
Next Document: Early postpartum hysterectomy: incidence and risk factors.